FX1
FX1 is a potent and specific BCL6 inhibitor, with an IC50 of around 35 μM.
Product Specifications
CAS Number
[1426138-42-2]
UNSPSC
12352005
Hazard Statement
H302
Target
Apoptosis; Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FX1.html
Purity
98.0
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O=C(O)CCN(C/1=O)C(SC1=C2C(NC3=C/2C=C(Cl)C=C3)=O)=S
Molecular Formula
C14H9ClN2O4S2
Molecular Weight
368.82
Precautions
H302
References & Citations
[1]Mariano G et al. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016 Sep 1; 126 (9) : 3351–3362.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1455341-01 0.02 mg (E-Coli)
Recombinant Human coronavirus HKU1 Spike glycoprotein (S), partial
Ask
View Details 
MBS1455341-02 0.1 mg (E-Coli)
Recombinant Human coronavirus HKU1 Spike glycoprotein (S), partial
Ask
View Details 
MBS1455341-03 1 mg (E-Coli)
Recombinant Human coronavirus HKU1 Spike glycoprotein (S), partial
Ask
View Details 
MBS1455341-04 5x 1 mg (E-Coli)
Recombinant Human coronavirus HKU1 Spike glycoprotein (S), partial
Ask
View Details